Association of Short-term Air Pollution Exposure With SARS-CoV-2 Infection Among Young Adults in Sweden.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
entrez:
20
4
2022
pubmed:
21
4
2022
medline:
23
4
2022
Statut:
epublish
Résumé
Mounting ecological evidence shows an association between short-term air pollution exposure and COVID-19, yet no study has examined this association on an individual level. To estimate the association between short-term exposure to ambient air pollution and SARS-CoV-2 infection among Swedish young adults. This time-stratified case-crossover study linked the prospective BAMSE (Children, Allergy Milieu, Stockholm, Epidemiology [in Swedish]) birth cohort to the Swedish national infectious disease registry to identify cases with positive results for SARS-CoV-2 polymerase chain reaction (PCR) testing from May 5, 2020, to March 31, 2021. Case day was defined as the date of the PCR test, whereas the dates with the same day of the week within the same calendar month and year were selected as control days. Data analysis was conducted from September 1 to December 31, 2021. Daily air pollutant levels (particulate matter with diameter ≤2.5 μm [PM2.5], particulate matter with diameter ≤10 μm [PM10], black carbon [BC], and nitrogen oxides [NOx]) at residential addresses were estimated using dispersion models with high spatiotemporal resolution. Confirmed SARS-CoV-2 infection among participants within the BAMSE cohort. Distributed-lag models combined with conditional logistic regression models were used to estimate the association. A total of 425 cases were identified, of whom 229 (53.9%) were women, and the median age was 25.6 (IQR, 24.9-26.3) years. The median exposure level for PM2.5 was 4.4 [IQR, 2.6-6.8] μg/m3 on case days; for PM10, 7.7 [IQR, 4.6-11.3] μg/m3 on case days; for BC, 0.3 [IQR, 0.2-0.5] μg/m3 on case days; and for NOx, 8.2 [5.6-14.1] μg/m3 on case days. Median exposure levels on control days were 3.8 [IQR, 2.4-5.9] μg/m3 for PM2.5, 6.6 [IQR, 4.5-10.4] μg/m3 for PM10, 0.2 [IQR, 0.2-0.4] μg/m3 for BC, and 7.7 [IQR, 5.3-12.8] μg/m3 for NOx. Each IQR increase in short-term exposure to PM2.5 on lag 2 was associated with a relative increase in positive results of SARS-CoV-2 PCR testing of 6.8% (95% CI, 2.1%-11.8%); exposure to PM10 on lag 2, 6.9% (95% CI, 2.0%-12.1%); and exposure to BC on lag 1, 5.8% (95% CI, 0.3%-11.6%). These findings were not associated with NOx, nor were they modified by sex, smoking, or having asthma, overweight, or self-reported COVID-19 respiratory symptoms. The findings of this case-crossover study of Swedish young adults suggest that short-term exposure to particulate matter and BC was associated with increased risk of positive PRC test results for SARS-CoV-2, supporting the broad public health benefits of reducing ambient air pollution levels.
Identifiants
pubmed: 35442452
pii: 2791305
doi: 10.1001/jamanetworkopen.2022.8109
pmc: PMC9021914
doi:
Substances chimiques
Nitrogen Oxides
0
Particulate Matter
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e228109Investigateurs
Catarina Almqvist
(C)
Niklas Andersson
(N)
Natalia Ballardini
(N)
Anna Bergström
(A)
Sophia Björkander
(S)
Petter Brodin
(P)
Anna Castel
(A)
Sandra Ekström
(S)
Antonios Georgelis
(A)
Lennart Hammarström
(L)
Qiang Pan-Hammarström
(Q)
Jenny Hallberg
(J)
Christer Jansson
(C)
Maura Kere
(M)
Inger Kull
(I)
André Lauber
(A)
Alexandra Lövquist
(A)
Erik Melén
(E)
Jenny Mjösberg
(J)
Ida Mogensen
(I)
Lena Palmberg
(L)
Göran Pershagen
(G)
Niclas Roxhed
(N)
Jochen Schwenk
(J)
Références
Eur Respir Rev. 2021 Feb 9;30(159):
pubmed: 33568525
Environ Pollut. 2022 Jan 1;292(Pt B):118369
pubmed: 34740737
Environ Toxicol Pharmacol. 2018 Jun;60:195-201
pubmed: 29734103
Science. 2021 Mar 26;371(6536):
pubmed: 33531384
Scand J Public Health. 2022 Feb;50(1):85-93
pubmed: 34148461
Epidemiology. 2000 May;11(3):320-6
pubmed: 10784251
Environ Resour Econ (Dordr). 2020;76(4):611-634
pubmed: 32836855
Sci Total Environ. 2020 Oct 15;739:140278
pubmed: 32758963
Environ Res. 2020 Apr;183:109190
pubmed: 32311903
Res Rep Health Eff Inst. 2002 Dec;(110):1-65; discussion 67-76
pubmed: 12578113
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Environ Epidemiol. 2022 Feb 04;6(1):e195
pubmed: 35169673
Environ Res. 2021 Apr;195:110722
pubmed: 33422505
Environ Health. 2003 Nov 20;2(1):15
pubmed: 14629774
J Frailty Aging. 2021;10(3):281-285
pubmed: 34105713
Paediatr Respir Rev. 2000 Dec;1(4):336-41
pubmed: 16263461
Euro Surveill. 2006;11(5):103-7
pubmed: 16757847
Environ Res. 2020 Nov;190:110042
pubmed: 32800895
Environ Health Perspect. 2017 Jun 16;125(6):067007
pubmed: 28669936
Environ Res. 2021 Jun;197:111024
pubmed: 33744266
Environ Pollut. 2021 Jan 1;268(Pt A):115897
pubmed: 33126032
Inhal Toxicol. 2007 Nov;19(14):1135-46
pubmed: 17987465
Sci Total Environ. 2020 Jul 20;727:138704
pubmed: 32315904
Environ Health Perspect. 2021 Nov;129(11):111303
pubmed: 34797163
Indoor Air. 2021 May;31(3):639-645
pubmed: 33131151
J Allergy Clin Immunol. 2022 Jan;149(1):65-75.e8
pubmed: 34695490
Environ Res. 2022 Mar;204(Pt B):112065
pubmed: 34534520
Environ Health Perspect. 2020 Sep;128(9):95001
pubmed: 32902328
Annu Rev Public Health. 2022 Apr 5;43:271-291
pubmed: 34982587
Eur Respir J. 2021 Aug 19;58(2):
pubmed: 34385271
Clin Transl Allergy. 2020 May 25;10:15
pubmed: 32489587
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
Lancet. 2011 Feb 26;377(9767):732-40
pubmed: 21353301
Environ Int. 2021 Jan;146:106255
pubmed: 33221596
Lancet Respir Med. 2014 Feb;2(2):131-40
pubmed: 24503268
Environ Health. 2014 Dec 04;13:102
pubmed: 25471661
Environ Health Perspect. 2021 Nov;129(11):117003
pubmed: 34787480
Int J Environ Res Public Health. 2017 Jul 07;14(7):
pubmed: 28686215
Trop Med Int Health. 2021 Apr;26(4):478-491
pubmed: 33319410